Browsing: relies

ALTERITY THERAPEUTICS LIMITED (ATHE) filed an annual report describing its development-stage neurology business focused on ATH434 for multiple system atrophy (MSA) and other Parkinsonian disorders. ATH434 is the lead and highly concentrated asset; Alterity reported positive FDA feedback and End‑of‑Phase 2 alignment on key elements of a registrational Phase 3 program.

Lanvin Group Holdings Ltd (symbol LANV) reported weaker top-line but improved profitability for the six months ended June 30, 2026. Revenue fell to €100.8 million, down 12.9% year over year, with declines across all four portfolio brands and all major regions, particularly Greater China and Other Asia. However, gross margin improved from 57.7% to 59.0%…

Independence Power Holdings, Inc. (ITXP) develops software and hardware for battery energy storage systems but remained pre-revenue in the three and six months ended June 30, 2026, reporting no revenue for either period. The company’s principal asset is the $86.6 million secured GridCore promissory note arising from a 2025 installation contract; it received about $1.7 million of…

Zoom has a brand awareness problem, but not in the way that you think. The tech company is trying to convince people that it’s an end-to-end, AI-first work platform rather than just a meetings platform, and it’s building an AI visibility strategy with creators to accomplish that.